Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-30
1996-04-16
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514325, 514655, 544380, 546203, 564366, 564389, 564391, 568308, 570183, C07D21170, A61K 31495, A61K 31445, A61K 31135
Patent
active
055082807
ABSTRACT:
This invention relates to novel derivatives of 5H-dibenzo (a,d)cycloheptenes, to the processes for their preparation, to their muscarinic receptor antagonist properties and to their end-use application for treating Parkinson's Disease, tardive dyskinesia, and motion sickness.
REFERENCES:
patent: 3436391 (1969-04-01), Holm
patent: 4816456 (1989-03-01), Sumners
patent: 5250681 (1993-10-01), Shoji et al.
patent: 5302602 (1994-04-01), Oshima et al.
patent: 5393890 (1995-02-01), Syoji et al.
The Bantam Medical Dictionary, (John Wiley & Sons, Publishers), p. 265 (1981).
Advanced Organic Chemistry by Jerry March (2nd Ed.), pp. 864-865 (1977).
Engelhardt et al, J. Med. Chem. II, pp. 325-332 (1968).
Hibert Marcel
Hijfte Luc Van
Moser Paul
Richards Mary
Bernhardt Emily
Merrell Pharmaceuticals Inc.
Moon Carolyn D.
LandOfFree
5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325314